Stock DANCAN DANCANN PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company Dancann Pharma A/S

Equities

DANCAN

DK0061410487

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2024-05-07 EDT 		5-day change 1st Jan Change
0.07 DKK -4.89% Intraday chart for Dancann Pharma A/S -2.78% +133.33%
03-29 Dancann Pharma Plans Up to DKK19 Million Rights Issue MT
02-28 DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge MT

Business Summary

Dancann Pharma A/S is a Denmark-based pharmaceutical biotechnology company powered by cannabinoids. The Company is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma manufactures and distributes prescription drugs (Rx drugs) and over-the-counter drugs (OTCs), mainly focused on pain patients with alternative needs.

Number of employees: 10

Sales per Business

DKK in Million2021Weight2022Weight Delta
Cannabinoid-based Drugs and Pharmaceuticals
100.0 %
1 100.0 % 6 100.0 % +553.09%

Sales per region

DKK in Million2021Weight2022Weight Delta
Denmark
100.0 %
1 100.0 % 6 100.0 % +553.09%

Managers

Managers TitleAgeSince
Jeppe Rasmussen FOU
 Founder 29 18-03-19
Peter Søndergaard DFI
 Director of Finance/CFO 52 23-01-03
Sarah Mai Lykke-Kjeldsen COO
 Chief Operating Officer 37 22-03-31
Jens Markussen PRN
 Corporate Officer/Principal - 21-03-08
Morten Martinsen PRN
 Corporate Officer/Principal 36 18-10-31

Members of the board

Members of the board TitleAgeSince
Carsten Trads CHM
 Chairman 69 -
Tue Østergaard BRD
 Director/Board Member 47 22-04-26
Jeppe Rasmussen FOU
 Founder 29 18-03-19
Alexander Schoeneck BRD
 Director/Board Member 41 22-09-21
Christian Carlsen BRD
 Director/Board Member 40 21-04-28
Louise Forman BRD
 Director/Board Member - 23-05-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 141,627,990 20,522,779 ( 14.49 %) 0 14.49 %

Company contact information

DanCann Pharma A/S

Rugvænget 5

6823, Ansager

+45 69 16 03 93

http://www.dancann.com
address Dancann Pharma A/S(DANCAN)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Annual profits - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
DANCANN PHARMA A/S Stock Dancann Pharma A/S
+133.33% 1.68M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+3.91% 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.87% 105B
ARGENX SE Stock argenx SE
+1.28% 22.25B
BIONTECH SE Stock BioNTech SE
-13.14% 22.09B
GENMAB A/S Stock Genmab A/S
-7.05% 18.68B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.36% 17.58B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.66% 16.85B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.75% 13.76B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.70% 12.46B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. DANCAN Stock
  4. Company Dancann Pharma A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW